Tin tức & Cập nhật

Taking tirzepatide once a week appears to result in clinically meaningful reductions in body weight for Japanese adults with obesity, according to the results of the phase III multicentre SURMOUNT-J trial

In children and adolescents who have contracted COVID-19, gastrointestinal (GI) tract symptoms may remain for up to 2 years, as reported in a large retrospective study.

The use of spaced transcranial direct current stimulation (tDCS) significantly reduces symptoms in patients with major depressive disorder (MDD), with no serious adverse events (AEs), reports a study.

A history of allergy, previous oxaliplatin exposure, and chemotherapy regimens are associated with a higher risk of oxaliplatin hypersensitivity reactions in patients with colorectal cancer, reveals a study.

A clinical research team from the University of Hong Kong (HKU) and an international team of genetic researchers have discovered that a rare neurodevelopmental syndrome is caused by mutations in the DDX39B gene.

Use of reduced-sodium, added-potassium salt substitutes vs regular salt is safe and significantly reduces risks of stroke recurrence and death, without increasing the risk of hyperkalaemia, a prespecified secondary analysis of the Salt Substitute and Stroke study (SSaSS) has shown.  

Hãy cùng nhìn lại những nghiên cứu, sáng kiến và nỗ lực không ngừng của Sanofi trong công cuộc bảo vệ sức khỏe cộng đồng trước cúm mùa trong bài viết này.

New drug applications approved by US FDA as of 1-15 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.